.png "Zydus Secures NMPA Clearance for Venlafaxine Generic")
Zydus Lifesciences has been granted consent by the National Medical Products Administration (NMPA) of China on its generic form of Venlafaxine Extended-Release capsules that is applied in the treatment of depressive and anxiety disorders...
Indian pharma companies Cipla, Natco Pharma, Hetero Labs, and Annora Pharma have achieved a breakthrough in China after securing key bids to supply generic drugs under the country’s latest volume-based procurement (VBP) program...
Teva Pharmaceuticals, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd., has announced new findings from the ongoing real-world IMPACT-TD Registry, which underscore the beneficial effects of AUSTEDO (deutetrabenazine) tablets and AUSTEDO XR
Ascelia Pharma AB (publ), a biotech focused on improving the life of people living with rare cancer conditions, announced the filing of a new patent application for its first-in-class orphan liver imaging drug Orviglance
Tata 1mg, one of India’s leading e-pharmacy platforms, has entered into a strategic alliance with ClickPost, a logistics intelligence company, to enhance and automate its medicine delivery network through AI-powered Performance-Based Courier
Granules India announced that its subsidiary, Granules Life Sciences (GLS), based in Hyderabad, has obtained approval from the U.S. Food and Drug Administration (FDA) for a product that underwent a pre-approval inspection (PAI)
Eli Lilly and Company has signed an agreement with MeiraGTx Holdings plc that grants Lilly global exclusive rights to MeiraGTx’s investigational gene therapy for a severe inherited retinal condition. The centerpiece of the deal is the programme...
Torrent Pharmaceuticals, the flagship company of the Torrent Group, Ahmedabad, is leading its next phase of growth through innovative chronic therapies and expansion in the emerging areas with high growth such as weight loss treatments.
The Oncology Subject Expert Committee (SEC), which is a part of the Central Drugs Standard Control Organisation (CDSCO), has advised that MSN Laboratories Pvt. Ltd. be given the green light to produce and sell Abiraterone Acetate
Roche’s experimental multiple sclerosis (MS) drug fenebrutinib has reached a major milestone, meeting its main goal in one of two late-stage trials for relapsing MS. The treatment sharply reduced annualised relapse rates over 96 weeks compared with..
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")